Company: BNBX
Filing Date: 2025-04-15
Form Type: DEF 14A
Source: 0001104659-25-034898
Chunk: 80

Company: BNB PLUS CORP.
Filing Date: 2025-04-15
Form: DEF 14A
Chunk 80
---
 | ​ | ​ | ​ | ​                                | $ | — | ​ | ​ | ​ | ​                         | $ | — | ​ | ​ | ​ | ​                               | $ | 387,623 | ​ | ​ |
| 2023 | ​ | ​ | ​                                             | $ | 468,000 | ​ | ​ | ​ | ​                                | $ | — | ​ | ​ | ​ | ​                         | $ | — | ​ | ​ | ​ | ​                               | $ | 468,000 | ​ | ​ |

(a)

The grant date fair value of equity awards represents the total of the amounts reported in the “Stock Awards” and “Option Awards” columns in the Summary Compensation Table for the applicable year.

​

(b)

There was no equity award adjustment for each of the applicable years shown above, as all equity awards granted were fully vested on the date of grant.

​

(3)

The dollar amounts reported in column (d) represent the average of the amounts reported for the Company’s named executive officers as a group (excluding Dr. Hayward, who has served as our Chairman, Chief Executive Officer and President) in the “Total” column of the Summary Compensation Table in each applicable year. The names of each of the named executive officers (excluding Dr. Hayward) included for purposes of calculating the average amounts in each applicable year are as follows: (i) for 2024 and 2023, Beth M. Jantzen, Clay Shorrock and Judith Murrah.

​

(4)

The dollar amounts reported in column (e) represent the average amount of “compensation actually paid” to the named executive officers as a group (excluding Dr. Hayward), as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the named executive officers as a group (excluding Dr. Hayward) during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the named executive officers as a group (excluding Dr. Hayward) for each year to determine the compensation actually paid, using the same methodology described above in Note 3:

​

| Year | ​ | ​ | AverageReportedSummaryCompensationTable Total forNon-PEO NEOs |   |         |   | ​ | ​ | AverageReportedValue of EquityAwards |   |         |   | ​ | ​ | Average EquityAwardAdjust